Clinical trials
Completed Lipid Metabolism Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
106 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 3 |
| 2007 | 4 |
| 2008 | 4 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 5 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 9 |
| 2015 | 3 |
| 2016 | 6 |
| 2017 | 13 |
| 2018 | 7 |
| 2019 | 8 |
| 2020 | 8 |
| 2021 | 6 |
| 2022 | 5 |
| 2023 | 6 |
| 2024 | 5 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 106 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 6 |
| Kastle Therapeutics, LLC | 5 |
| University of Texas Southwestern Medical Center | 4 |
| Akcea Therapeutics | 3 |
| University of Colorado, Denver | 3 |
| 89bio, Inc. | 2 |
| BTL Industries Ltd. | 2 |
| Caliway Biopharmaceuticals Co., Ltd. | 2 |
| Eli Lilly and Company | 2 |
| Maastricht University Medical Center | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lipid Metabolism Disorders | 106 |
| Dyslipidemias | 30 |
| Metabolic Diseases | 26 |
| Hyperlipidemias | 22 |
| Hypercholesterolemia | 17 |
| Obesity | 16 |
| Glucose Metabolism Disorders | 10 |
| Cardiovascular Diseases | 9 |
| Genetic Diseases, Inborn | 8 |
| Hypertriglyceridemia | 8 |
Trials
Showing 51 to 75 of 106. Each trial links to its page on Pharma Observatory.
6 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.